Better patient outcomes with high-performing thyroid assaysImmunoassay results you can count on

It is estimated that 200 million people1 in the world have some form of thyroid disease: hypothyroidism, hyperthyroidism, or thyroid cancer. One in 20 people most likely will experience a thyroid problem at some stage in life; many are undiagnosed or misdiagnosed.

To assess thyroid gland function, physicians can request several laboratory tests that measure the amounts of different hormones and autoantibodies in the blood.

Add these assays to your thyroid test menu and support clinicians in detecting, diagnosing, and monitoring thyroid dysfunction.

Atellica IM Tg Assay

Evaluation of the Atellica IM Thyroglobulin (Tg) Assay

Evaluation of the Atellica IM Thyroglobulin (Tg) Assay Clinical Brief

A valuable component in the monitoring of differentiated thyroid cancer

  • Aids in monitoring differentiated thyroid cancer patients who have undergone thyroidectomy with or without radioiodine ablation.
  • Supports better clinical decisions with an LoQ of 0.05 ng/mL (0.076 pmol/L).
  • Reduces risk of misdiagnosis resulting from interference by biotin or anti-ruthenium antibody interferences.

IMMULITE 2000/2000 XPi TSI Assay

TSI Literature Compendium

TSI Literature Compendium: Third party articles comparing the diagnostic value of the IMMULITE 2000 TSI assay (a bridge assay) to TRAb assays

A powerful diagnostic tool for the differential diagnosis of Graves’ disease

  • Accurate results with 98.3% clinical sensitivity and 99.7% clinical specificity.
  • Improved operational efficiency with ready-to-use, stable primary assay reagents requiring no manual preparation.
  • Designed to reduce thyrotropin-blocking antibody detection with the objective of more-specific detection of thyroid-stimulating antibody.

Atellica IM and ADVIA Centaur aTgII Assay

Analytical and Clinical Performance of the ADVIA Centaur Anti-thyroglobulin (aTgII) Assay*

Analytical and Clinical Performance of the ADVIA Centaur Anti-thyroglobulin (aTgII) Assay Clinical Brief

A key aid in the diagnosis of Hashimoto's and Graves' diseases

  • Delivers fast, actionable results with a fully automated assay that can provide results in as little as 18 minutes.
  • Combines strong analytical performance with an LoQ of 1.4 IU/mL.
  • Standardized to the World Health Organization (WHO) International Reference Preparation, Anti-Thyroglobulin Serum, Human (NIBSC 65/093), and reports results in IU/mL.

    Explore our broad and growing test portfolio across disease states

    Interested in learning more about our integrated chemistry and immunoassay system, the Atellica Solution?